Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 15, 2020 / 02:15PM GMT
Release Date Price: $225.3 (+2.40%)
Rivka Regina Goldwasser
Morgan Stanley, Research Division - MD

Welcome to our next session here at Morgan Stanley's Global Healthcare Conference. I'm Ricky Goldwasser, Morgan Stanley's health care services research analyst. And joining me this morning is Jim Foster, CEO of Charles River.

And before we get started, please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley's employees only. It's not for a member of the press. And if you are a member of the press, please disconnect and reach out separately. And for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com. And if you have any questions, please reach out to your Morgan Stanley sales representative.

And with that, I'll hand it off to you, Jim, for some introductory remarks.

James C. Foster
Charles River Laboratories International, Inc. - Chairman, CEO & President

Sure. Thanks, Ricky. Nice to see you, albeit virtually. We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot